Normal view MARC view ISBD view

Iridium-catalyzed asymmetric hydrogenation of unfunctionalized, trialkyl-substituted olefins. [electronic resource]

By:

Wang, Aie

Contributor(s):

Producer: 20110509Description: 599-606 p. digitalISSN:

1861-471X

Subject(s):

Online resources:

Available from publisher's website

In: Chemistry, an Asian journal vol. 6

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 Are formalin-fixed and paraffin-embedded tissues fit for proteomic analysis?
by Bayer, Malte
2 RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations.
by Brabetz, Oliver
3 A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS.
by Rolfes, Leoni
4 AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.
by Mikesch, Jan-Henrik
5 Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer.
by Angenendt, Linus
6 Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature.
by Börschel, Niklas
7 Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease.
by Angenendt, Linus
8 NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
by Brand, Caroline
9 A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia.
by Schliemann, Christoph
10 Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.
by Wethmar, Klaus
11 Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancer.
by Mikesch, Jan-Henrik
12 Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
by Schliemann, Christoph
13 Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.
by Kessler, Torsten
14 Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.
by Oellerich, Thomas
15 The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.
by Angenendt, Linus
16 Chromosomal Abnormalities and Prognosis in
by Angenendt, Linus